Journal of Molecular Biomarkers & Diagnosis

2^nd World Congress on Biomarkers & Clinical Research

12-14 September 2011 Baltimore, USA

Scientific Tracks Abstracts

• Color-coded Z scores for the display and analysis of biomedical data

  Robert A. Warner

  PDF HTML

• Heat acclimation associated with decreased of urinary 8-hydroxydeoxyguanosine in navy boiler tender

  Yung-Kai Huang, Chen-Chen Chang, Che-Yi Lai, Hsin-Hsiu Huang and Horn-Che Chiang

  PDF HTML

• Dose time of presentation of patients of severe sepsis determines the clinical outcome?

  Fahad Aziz

  PDF HTML

• Biomarkers for novel diabetes therapies in early clinical development. Examples on markers of target activity, gene expression, effi cacy and safety from an 11-beta HSD1 inhibitor program

  Jan W Eriksson

  PDF HTML

• Tatjana Abaffy

  PDF HTML

• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA

  Naoko Sueoka-Aragane, Tomomi Nakamura, Kentaro Iwanaga, Akemi Sato, Kazutoshi Komiya, Tomonori Abe, Norio Ureshino, Shinichiro Hayashi, Toshiya Hosomi, Mitsuharu Hirai, Eisaburo Sueoka and Shinya Kimura

  PDF HTML

• Centrosomal Nlp is an oncogenic protein that has a close relationship with tumorigenesis

  Shao Shujuan

  PDF HTML

• Next generation of biomarkers: Serum antibody repertoire profi ling using next generation sequencing

  Yurij Ionov

  PDF HTML

• Noninvasive molecular diagnosis of human visceral leishmaniasis

  Manisha Vaish, Jaya Chakravarty and Syam Sundar

  PDF HTML

• Brain-derived neurotrophic factor as a biomarker of acute episodes in bipolar disorder: meta-regression analysis

  Brisa S. Fernandes

  PDF HTML

• Angiogenic activities of YKL-40 in cancer development: A potential biomarker and target for cancer diagnosis and therapy

  Rong Shao

  PDF HTML

• Genetic biomarkers for metastatic melanoma

  Stanley P. L. Leong, Botoul Maqsodi, Wilson Lew Yunqing Ma, RaziaKhan, Takuro Yaoi, John C. Moretto, Brigitte Robert, George Bers, Mohammed Kashani-Sabet1and Gary K. McMaster

  PDF HTML

• Proteomic approaches for profi ling cancer signaling pathways

  Fei Ye

  PDF HTML

• Ultra-sensitive detection of BRAF V600E and G469A mutations by Ice COLD-PCR and BLOCker- Sequencing

  Yanggu Shi, Benjamin Legendre, Jr., Tyler Borcyk, Phil Eastlake and Katherine Richardson

  PDF HTML

• From bench to bedside

  Gargi D Basu

  PDF HTML

• Cancer biomarkers: from discovery to clinical implementation

  Renaud Seigneuric

  PDF HTML

• Label-free optical bio-sensors for proteomic analysis: current applications and future development in cancer research

  Valentina Donzella

  PDF HTML

• Secretome analysis of large cell lung cancer cell lines using two-dimensional electrophoresis coupled to mass spectrometry

  Zahra Mojtahedi

  PDF HTML

• Copro-antiapoptotic protein survivin and lactoferrin biomarkers for improved detection and nanodelivery to colon cancer

  Jagat R Kanwar, Ganesh Mahidhara, Rupinder K Kanwar and Chun Hei Antonio Cheung

  PDF HTML

• Cancer bioinformatics, a potential way for prediction of chemotherapeutic responses in clinics

  Da-Yong Lu, Ting-Ren Lu and Xue-Liang Chen

  PDF HTML

• Development and prospective evaluation of a 20-gene model for molecular nodal staging of bladder cancer

  Alexander Baras

  PDF HTML

• Utility of ß-2 microglobullin as a housekeeping gene in human cancerous colorectal tissue

  Yasuhiro Nihon-Yanagi

  PDF HTML

• Myocardial CXCR4 interaction with ß2-adrenergic receptor: a potential therapeutic approach for congestive heart failure

  Sima T. Tarzami

  PDF HTML

• Infl uence of total PSA, BNP, GAMMA-GT, haemoglobin, blood urea nitrogen, glucose, triglycerides and renal failure on D-DIMER levels among central Africans with congestive heart failure

  Longo-Mbenza B, Ntima Mamona G, Forka AC, Vangu Nzita M and Kianu Phanzu B

  PDF HTML

• Biomarkers of brain function in children with uncomplicated epilepsy

  Sherifa A. Hamed

  PDF HTML

• Theurapetic hypothermia for postresuscitation syndrome and lactate levels

  Sule AKIN

  PDF HTML

• The roles of human apurinic/ apyrimidinic endonuclease/redox effector factor (APE1/Ref-1) in tumor diagnosis and related mechanism study

  Nan Dai

  PDF HTML

• Molecular characterization and current treatment strategy of glioblastoma multiforme

  Xiang Zhang, Wei Zhang, Weidong Cao, Gang Cheng, Yongqiang Zhang, Bo-lin Liu and Jin-xiang Cheng

  PDF HTML

• Individualized cancer chemotherapy

  Da-Yong Lu and Ting Ren Lu

  PDF HTML

• Prognostic value of troponin i & probrian natriuretic peptide in patients with sever sepsis: A closed unit experience

  Fahad Aziz

  PDF HTML

• Sulphonylureas: Do we need to introspect safety again?

  Devindra Sehra, Sudhish Sehra and Shiv Tej Sehra

  PDF HTML

• Blood-based test for multiple sclerosis - biomarkers for disease detection and monitoring of treatment

  Victor V. Levenson

  PDF HTML

• From research to the clinic: lessons from BCR ABL dosage in the tyrosine kinase inhibitors era

  Jean Gabert, Nathalie Beaufils

  PDF HTML

• PNA technology for diagnosis of infectious and genetic diseases

  Irina Smolina

  PDF HTML

• Molecular diagnostic system for gliomas based on gene expression profiling

  Mitsuaki Shirahata, Shigeyuki Oba, Yoshitaka Narita, Yoshihiro Muragaki, MotohikoMaruno, Ryo Matoba, Susumu Miyamoto, Kikuya Kato

  PDF HTML

• Direct detection of circulating tumor cells (CTCs) in blood using digital cast PCR for early detection of lung cancer

  Caifu Chen, David Deng, Fawn Wang, Yun Bao, David Merrill, and Pius Brzoska

  PDF HTML

• Biotransformation of citral by Saccharomyces cerevisae and Aspergillus niger

  Akbar Esmaeili

  PDF HTML

• Investigation of novel biomarkers for Alzheimer's disease using lipid-coated nanoparticles

  Hitoshi Sohma, Mami Yamaguchi, Michitoshi Kimura, Shin-ichi Imai, Kayo Matsumoto, Norio Takei and Yasuo Kokai

  PDF HTML

• Development of a microRNA assay for evaluating genotoxicity of agents

  Tao Chen

  PDF HTML

• Biomarkers in the age of integromics

  Hakima Amri

  PDF HTML

• Quantitative imaging of infl ammation toward diagnosis of systemic infl ammation and tumor growth

  Moonsoo M. Jin

  PDF HTML

• Genome annotation, with implications for biomarkers

  Mark Gerstein

  PDF HTML

• Biomarkers in drug discovery: potential use versus challenges

  Abdel Halim

  PDF HTML

• 12-Lipoxygenase Regulation of Platelet-Mediated Hemostasis and Thrombosis

  Michael Holinstat

  PDF HTML

• The search for safe compounds, robust assays and better drug delivery systems for improved anticancer activity

  Crispin R. Dass

  PDF HTML

• Potential Application of Nitrate reductase as biomarker in identifying novel inhibitors against M.tuberculosis

  Dhiman Sarkar

  PDF HTML

• Bromotyrosine derivatives isolated from marine sponges as antiparasitary

  Elkin Galeano, Olivier P. Thomas, Sara Robledo, Diana Muñoz and Alejandro Martínez

  PDF HTML

• Protease finger printing for biomarker discovery

  Kalyani Jambunathan, Douglas S. Watson and Amit K. Galande

  PDF HTML

• Novel peptides targeting circulating cellular biomarkers for molecular imaging of tumor angiogenesis

  Anka N. Veleva

  PDF HTML

• Seeing, counting and phenotyping exosomes as biomarkers using nanoparticle tracking analysis

  Jeremy Warren and Bob Carr

  PDF HTML

• Compare bayesian evaluation of biomarkers as surrogate endpoints with the frequency form

  Shohreh Jalaie, Soghrat Faghihzadeh, Farzad Eskandari and M.Reza Meshkani

  PDF HTML

• Effect of carvacrol on D-galactosamineinduced mitochondrial enzymes and DNA damage by single-cell gel Electrophoresis

  Balakrishnan Aristatile, Khalid S.Al - Numair, Abdullah. H. Al - Assaf1 and Kodukkur Viswanathan Pugalendi

  PDF HTML

• Biopolymer Nanotherapeutics: Enabling oncology drug development by Nanoconjugates & nanoparticles

  Anita Kamra Verma

  PDF HTML

• Urinary microRNAs as noninvasive biomarkers for drug-induced liver injury

  Xi Yang

  PDF HTML

• Biomarkers: Evolving regulatory landscape for drug development and diagnostics

  Orest Hurko

  PDF HTML

• Utilization and cost of prostate-specifi c antigen (PSA) as a biomarker among prostate cancer patients: Results from Taiwan national health insurance research database

  Yi-Hsien Lin

  PDF HTML